← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ligocyte Pharmaceuticals, Inc.
Bozeman, MT
$9,483,114
Total funding
5
Grants
Funding mix
By agency
NIH$9,483,114 · 5
By mechanism
UC1$4,698,162 · 1
R44$3,262,478 · 1
R43$1,309,487 · 2
R41$212,987 · 1
Investigators at Ligocyte Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preclinical Development of Non-Invasive Anthrax Vaccine$4,698,162
UC1 · FY2005 · AI
RATIONAL DESIGN OF ADHESION BLOCKING ANTI-INFLAMMATORIES$1,450,152
R44 · FY2001 · AI
RATIONAL DESIGN OF ADHESION BLOCKING ANTI-INFLAMMATORIES$1,294,354
R44 · FY2000 · AI
RATIONAL DESIGN OF ADHESION BLOCKING ANTI-INFLAMMATORIES$517,972
R44 · FY2002 · AI
Anthrax Vaccine Formulations Combining PA/Spore Epitopes$436,928
R43 · FY2004 · AI
Group B Streptococcal Peptide Mimetic Vaccine$299,937
R43 · FY2002 · AI
Anthrax Vaccine Formulations Combining PA/Spore Epitopes$291,720
R43 · FY2005 · AI
Group B Streptococcal Peptide Mimetic Vaccine$280,902
R43 · FY2003 · AI
Tubercle Bacilli Binding to Host Cells: Vaccine Design$212,987
R41 · FY2002 · AI